The FDA has approved Pfizer and Moderna’s new 2026–2027 XFG-adapted mRNA COVID-19 vaccines even though the XFG-specific evidence publicly presented to regulators was preclinical animal data involving just 8–10 mice per group.
The reach of these dangerous approvals is sweeping: …
